1. Home
  2. IXHL

as of 01-22-2026 4:00pm EST

$0.36
+$0.01
+2.75%
Stocks Nasdaq

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Founded: 2001 Country:
Australia
Australia
Employees: N/A City: NORWEST NSW
Market Cap: 134.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 7.5M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.44 EPS Growth: N/A
52 Week Low/High: $0.08 - $2.25 Next Earning Date: 02-13-2026
Revenue: $12,000 Revenue Growth: -86.05%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered IXHL Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 0.00%
0.00%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Incannex Healthcare Inc. News

IXHL Breaking Stock News: Dive into IXHL Ticker-Specific Updates for Smart Investing

All IXHL News

Share on Social Networks: